Showing Funds Performance since Sep 07, 2020

| Duration | Fund Return(%) | Category Average(%) | Category Best(%) |
|---|---|---|---|
| 1M | 2.54 | 0.24 | 13.06 |
| 6M | 16.16 | 1.77 | 125.97 |
| 1Y | 20.26 | 4.54 | 202.92 |
| 3Y | 0.00 | 13.01 | 342.40 |
HDFC Pharma and Healthcare Fund Growth managed by HDFC Mutual Fund,is a Equity - Sector Fundscheme with Assets Under Management of ₹2,362 Crore. The fund benchmarks its performance against the BSE Healthcare while maintaining an expense ratio of 1.97. Under the expert guidance of Nikhil Mathur ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.
Mr. Nikhil Mathur holds PGDM - IMT, Ghaziabad, B.E. (Civil) - PEC, Chandigarh, CFA (USA) level 3 cleared. He has over 7 years of experience in equity research and 2 years in financial advisory.
| Fund Name | Ratings | AUM | Expense Ratio |
|---|---|---|---|
| WhiteOak Capital Banking & Financial Services Fund Growth | 0 | 592.5 CR | 2.44 |
| SBI Energy Opportunities Fund Growth | 5 | 8906.34 CR | 1.76 |
| HDFC Pharma and Healthcare Fund Growth | 0 | 2362.44 CR | 1.97 |
| HDFC Defence Fund Growth | 5 | 9724.27 CR | 1.75 |
| Nippon India Taiwan Equity Fund Growth | 3 | 1256.27 CR | 2.15 |
| Fund Name | 1Y | 3Y |
|---|---|---|
| This FundWhiteOak Capital Banking & Financial Services Fund Growth | 3.9517 | 0 |
| This FundSBI Energy Opportunities Fund Growth | 9.3981 | 0 |
| This FundHDFC Pharma and Healthcare Fund Growth | 20.2629 | 0 |
| This FundHDFC Defence Fund Growth | 14.9064 | 189.4226 |
| This FundNippon India Taiwan Equity Fund Growth | 198.7903 | 324.3981 |